glutathione s transferase p 2 S-Transferases in Cancer Glutathione-S-Transferases as Potential Targets for
Description
A., Hornberger, J
Targeting BRG1 reduced lipid metabolism, thereby reducing tumor cell proliferation, and therefore, BRG1 is expected to be used in the epigenetic treatment of TNBC
Steinel, N
Take Control of Your Neuropathy Don't let peripheral neuropathy control your life
These non-coding RNAs can be grouped according to their size, the most common being long non-coding RNAs (lncRNAs) and microRNAs
All patients were given treatment and noted resolution of symptoms mostly within 2 5 days
